Every protocol is preceded by physician consultation, baseline labs, and clinical assessment of fit
However, a small number of GHR antagonists are in clinical trials or preclinical development, and we anticipate that these will eventually expand the options available for clinical and research applications
In some cases, switching to a different medication with a different pharmacokinetic profile may improve tolerability
Its small size (only three amino acids) and endogenous origin contribute to its excellent tolerability
Even when a second protocol is being run alongside KLOW in research, it is kept as a physically separate draw: its own reconstitution, its own concentration, its own units, its own site
Her research focuses on GHK's potential to reverse epigenetic changes associated with aging, cancer metastasis, and COPD